Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
Karmanos Cancer Institute, Detroit, Michigan Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah Last updated November 2025